Nadolol Tablet
Product Images NDC 68001-318

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nadolol (NDC 68001-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4d401693 53ab 4d63 9f25 39fe5ddca2a1 01)

Chemical structure of Nadolol showing its molecular formula C17H27NO4 and molecular weight 309.40. The diagram depicts its functional groups and carbon ring system, representing its chemical composition as used in the medication Nadolol tablets by BluePoint Laboratories.*

FDA Label Image

Nadolol Tablets 20 mg

Nadolol 20 mg Tablets, USP, oral tablets packaged by BluePoint Laboratories. This label indicates a bottle containing 100 tablets with each tablet containing 20 mg of nadolol. Storage instructions specify to keep tightly closed, protect from light, and store at 20 to 25°C (68 to 77°F). The label also includes the NDC number 68001-317-00 and a QR code, along with manufacturer information for InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd.*

FDA Label Image

Nadolol Tablets 40 mg

Nadolol 40 mg Tablets, USP label from BluePoint Laboratories. The label indicates the product is a prescription oral tablet containing 40 mg of nadolol per tablet, supplied in a bottle of 100 tablets. Storage instructions advise keeping the bottle tightly closed, protecting from light, and storing at 20° to 25°C (68° to 77°F). Manufacturer details show InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd., Hauppauge, NY.*

FDA Label Image

Nadolol Tablets 80 mg

Nadolol 80 mg tablets, USP oral dosage form packaging label. The label shows the BluePoint Laboratories logo and indicates the bottle contains 100 tablets. It includes storage instructions and manufacturer information for InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd. The label also displays the National Drug Code (NDC) 68001-319-00, a barcode, and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.